Company news

Evolus, Inc. Common Stock news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Evolus to Report First Quarter 2022 Results and Provide Business Update

April 25, 2022

Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®

March 30, 2022

Evolus Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Update

March 2, 2022

Evolus Announces Retirement of Chief Financial Officer Lauren Silvernail

March 2, 2022

Evolus Names Christos Monovoukas Senior Vice President of Corporate Development

February 28, 2022

Evolus to Report Fourth Quarter and Year End 2021 Results and Provide Business Update

February 16, 2022

Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva®

February 7, 2022

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Net Revenue and Provides 2022 Guidance

January 25, 2022

Evolus Expands Board of Directors With Appointment of Digital and Beauty Innovator Brady Stewart

January 4, 2022

Evolus Joins Nasdaq Biotechnology Index

December 19, 2021

Evolus Enters Into $125 Million Credit Facility with Pharmakon Advisors

December 13, 2021

Evolus Announces Participation in November Investment Conferences

November 8, 2021

Evolus Reports Third Quarter 2021 Results and Provides Business Update

November 1, 2021

Evolus Announces Appointment of Jessica Novak as Senior Vice President, Human Resources

October 31, 2021

Evolus to Report Third Quarter 2021 Results and Provide Business Update

October 21, 2021

Evolus Announces Participation in September Investment Conferences

September 1, 2021

Evolus Reports Second Quarter 2021 Results and Provides Business Update

August 3, 2021

Evolus to Report Second Quarter 2021 Results and Provide Business Update

July 21, 2021

Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations

June 29, 2021

Evolus Appoints Dan Stewart as Vice President and General Manager, International

May 18, 2021

Evolus Reports First Quarter 2021 Results and Provides Business Update

May 11, 2021

Evolus to Report First Quarter 2021 Results and Provide Business Update

May 3, 2021

Evolus Announces Proposed Public Offering of Common Stock

April 20, 2021

Evolus Announces Pricing of Public Offering of Common Stock

April 20, 2021

Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update

March 23, 2021

Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update

March 22, 2021

Evolus Announces Promotion of Crystal Muilenburg to Chief Marketing Officer

February 25, 2021

Evolus Announces Preliminary, Unaudited, Fourth Quarter and Full Year 2020 Net Revenue

February 22, 2021

Evolus Reports Third Quarter 2020 Results and Provides Business Update

October 28, 2020

Evolus Announces Promotion of Michael Mazen Jafar to Chief Commercial Officer and Jeff Plumer to General Counsel

October 28, 2020

Evolus Reports Second Quarter 2020 Results and Provides Business Update

August 9, 2020

Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020

July 26, 2020

Evolus Strengthens Balance Sheet; Secures $40 Million Investment

July 5, 2020

Evolus Provides Update on United States International Trade Commission (USITC) Case

July 5, 2020

Evolus Reports First Quarter 2020 Results and Provides Business Update

May 10, 2020

Evolus to Report First Quarter 2020 Financial Results and Provide a Business Update on Monday, May 11, 2020

May 5, 2020

Evolus Provides Strategic Business Update

April 15, 2020

Evolus Provides Update on International Trade Commission (ITC) Case

March 3, 2020

Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update

February 24, 2020

Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020

February 11, 2020

Evolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue

January 8, 2020

Evolus Reports Third Quarter 2019 Financial Results and Provides Business Update

November 3, 2019

Evolus and Clarion Medical Technologies Announce First Shipment of Nuceiva™ (prabotulinumtoxinA) to Customers in Canada

October 15, 2019

Evolus Receives Approval for Nuceiva™ in the European Union

September 30, 2019

← Newer news releases

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.